Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent C Tam

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Therapeutic Advances in Medical Oncology|July 29, 2025
Role of immune checkpoint inhibitor combinations in resectable and unresectable, embolization-eligible hepatocellular carcinomaBrandon M Meyers, Howard J Lim, Mayur Brahmania, et al.
Current Oncology (Toronto, Ont.)|July 25, 2025
Pemigatinib in the Real-World Management of Cholangiocarcinoma Through a Canadian Patient Support ProgramPhilip Q Ding, Vincent C Tam, Ravi Ramjeesingh, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Genomic analysis of the Mozambique strain of Vibrio cholerae O1 reveals the origin of El Tor strains carrying classical CTX prophageShah M Faruque, Vincent C Tam, Nityananda Chowdhury, et al.
Cell|July 6, 2013
Lipidomic profiling of influenza infection identifies mediators that induce and resolve inflammationVincent C Tam, Oswald Quehenberger, Christine M Oshansky, et al.
Cancer|August 18, 2017
Drug development for breast, colorectal, and non-small cell lung cancers from 1979 to 2014Nancy A Nixon, Omar F Khan, Hasiba Imam, et al.
Journal of Gastrointestinal Oncology|May 19, 2025
A retrospective database analysis to understand treatment patterns and outcomes of intermediate and advanced hepatocellular carcinoma in Alberta, Canada (A-CAPTAIN study)Carla P Amaro, Chloe A Lim, Philip Q Ding, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 26, 2020
PPARα exacerbates necroptosis, leading to increased mortality in postinfluenza bacterial superinfectionVincent C Tam, Rosa Suen, Piper M Treuting, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 9, 2017
The Evolution of Metastatic Colorectal Cancer Clinical Trials: Application of the ASCO Framework for Assessing ValueDoreen A Ezeife, Sunil Parimi, Ellen R Cusano, et al.
Therapeutic Advances in Gastroenterology|October 6, 2022
Impact of NAFLD on clinical outcomes in hepatocellular carcinoma treated with sorafenib: an international cohort studyJessica Howell, Amit Samani, Binish Mannan, et al.
Cancer Medicine|May 8, 2020
Second-line treatment of hepatocellular carcinoma after sorafenib: Characterizing treatments used over the past 10 years and real-world eligibility for cabozantinib, regorafenib, and ramucirumabAndrea S Fung, Vincent C Tam, Daniel E Meyers, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Therapeutic Advances in Medical Oncology|July 29, 2025
Role of immune checkpoint inhibitor combinations in resectable and unresectable, embolization-eligible hepatocellular carcinomaBrandon M Meyers, Howard J Lim, Mayur Brahmania, et al.
Current Oncology (Toronto, Ont.)|July 25, 2025
Pemigatinib in the Real-World Management of Cholangiocarcinoma Through a Canadian Patient Support ProgramPhilip Q Ding, Vincent C Tam, Ravi Ramjeesingh, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Genomic analysis of the Mozambique strain of Vibrio cholerae O1 reveals the origin of El Tor strains carrying classical CTX prophageShah M Faruque, Vincent C Tam, Nityananda Chowdhury, et al.
Cell|July 6, 2013
Lipidomic profiling of influenza infection identifies mediators that induce and resolve inflammationVincent C Tam, Oswald Quehenberger, Christine M Oshansky, et al.
Cancer|August 18, 2017
Drug development for breast, colorectal, and non-small cell lung cancers from 1979 to 2014Nancy A Nixon, Omar F Khan, Hasiba Imam, et al.
Journal of Gastrointestinal Oncology|May 19, 2025
A retrospective database analysis to understand treatment patterns and outcomes of intermediate and advanced hepatocellular carcinoma in Alberta, Canada (A-CAPTAIN study)Carla P Amaro, Chloe A Lim, Philip Q Ding, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 26, 2020
PPARα exacerbates necroptosis, leading to increased mortality in postinfluenza bacterial superinfectionVincent C Tam, Rosa Suen, Piper M Treuting, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 9, 2017
The Evolution of Metastatic Colorectal Cancer Clinical Trials: Application of the ASCO Framework for Assessing ValueDoreen A Ezeife, Sunil Parimi, Ellen R Cusano, et al.
Therapeutic Advances in Gastroenterology|October 6, 2022
Impact of NAFLD on clinical outcomes in hepatocellular carcinoma treated with sorafenib: an international cohort studyJessica Howell, Amit Samani, Binish Mannan, et al.
Cancer Medicine|May 8, 2020
Second-line treatment of hepatocellular carcinoma after sorafenib: Characterizing treatments used over the past 10 years and real-world eligibility for cabozantinib, regorafenib, and ramucirumabAndrea S Fung, Vincent C Tam, Daniel E Meyers, et al.
Pageof 5